BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs2300478, BRCA1, Angiogenesis, Diabetes mellitus, Adipose tissue, Alcohol, Prozac)
Bookmark Forward

QuickView for RNA Pol II (gene)


Body Atlas

Most Correlated Tissues

  1. Dendritic (plasmacytoid) cell
  2. Basophil of peripheral blood
  3. Skeletal muscle
  4. T Lymphocyte (regulatory) of peripheral blood
  5. Eosinophil of peripheral blood
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Ebola virus disease
  2. Thyroid eye disease
  3. Disorder of eye
  4. Multiple-resistant Staphylococcus aureus infection
  5. Disorder related to transplantation
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Antigens, Neoplasm
  2. CXCR4 Peptide Antagonist LY2510924
  3. HAMLET complex, human
  4. pou5f1 protein, zebrafish
  5. IGF2 protein, human
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. FAM110B
  2. DEAF1
  3. SART3
  4. KCNA1
  5. wg
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. TANGO6 regulates cell proliferation via COPI vesicle-mediated RPB2 nuclear entry.
  2. The RNA polymerase II subunit B (RPB2) functions as a growth regulator in human glioblastoma.
  3. The Siderophore Transporters Sit1 and Sit2 Are Essential for Utilization of Ferrichrome-, Ferrioxami…
  4. The low copy nuclear region, RPB2 as a novel DNA barcode region for species identification in the ra…
  5. Promoter clearance by RNA polymerase II.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Quantification of Antisense HIV RNA in Patients
  2. Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HI…
  3. Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acu…
  4. Investigation of V520 in an HIV Vaccine Proof-of-Concept Study (V520-023)
  5. ITV Extension Study
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.